Search

Issue
Title
Authors
Vol 31, No 35 (2024)
Recent Developments in Coumarin Derivatives as Neuroprotective Agents
Mishra P., Kumar A., Kaur K., Jaitak V.
PDF
(Eng)
Vol 31, No 14 (2024)
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy
Cui Y., Zhang J., Zhang G.
PDF
(Eng)
Vol 31, No 7 (2024)
Dihydrofolate Reductase (DHFR) Inhibitors: A Comprehensive Review
Sehrawat R., Rathee P., Khatkar S., Akkol E., Khayatkashani M., Nabavi S., Khatkar A.
PDF
(Eng)
Vol 31, No 30 (2024)
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus
Lukic N., Macvanin M., Gluvic Z., Rizzo M., Radak D., Suri J., Isenovic E.
PDF
(Eng)
Vol 31, No 22 (2024)
Synthesis of β-Amino Carbonyl 6-(Aminomethyl)- and 6-(Hydroxymethyl)pyrazolopyrimidines for DPP-4 Inhibition Study
Chung C., Tseng C., Li S., Zeng W., Lin Y., Hu Y., Jiang W., Huang G., Tsai H., Wong F.
PDF
(Eng)
Vol 31, No 36 (2024)
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review
Metwally K., Abo-Dya N.
PDF
(Eng)
Vol 31, No 5 (2024)
Imidazo[4,5-b]Pyridines: From Kinase Inhibitors to more Diversified Biological Properties
Jarmoni K., Misbahi K., Ferrières V.
PDF
(Eng)
Vol 31, No 30 (2024)
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults
De S.
PDF
(Eng)
Vol 31, No 2 (2024)
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies
Sheikh K., Iqubal A., Alam M., Akhter M., Khan M., Ehtaishamul Haque S., Parvez S., Jahangir U., Amir M., Khanna S., Shaquiquzzaman M.
PDF
(Eng)
Vol 31, No 20 (2024)
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications
Chen P., Lou L., Sharma B., Li M., Xie C., Yang F., Wu Y., Xiao Q., Gao L.
PDF
(Eng)
Vol 31, No 38 (2024)
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors
Shihab W., Kubba A., Tahtamouni L., Saleh K., AlSakhen M., Kanaan S., Saleh A., Yasin S.
PDF
(Eng)
Vol 31, No 3 (2024)
Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present)
Beltran E., Serafini M., Alves I., Aragón Novoa D.
PDF
(Eng)
Vol 31, No 2 (2024)
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu
Yaribeygi H., Maleki M., Sathyapalan T., Rizzo M., Sahebkar A.
PDF
(Eng)
Vol 31, No 20 (2024)
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors
Du S., Fang Y., Zhang W., Rao G.
PDF
(Eng)
Vol 31, No 29 (2024)
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials
Heydari B., Sahebnasagh A., Omrani M.A., Azimi S., Dehghani M.H., Salehi-Abargouei A., Farman F., Saghafi F.
PDF
(Eng)
Vol 31, No 16 (2024)
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?
González J., Salas-Sarduy E., Alvarez L., Valiente P., Arni R., Pascutti P.
PDF
(Eng)
Vol 31, No 9 (2024)
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)
De S.
PDF
(Eng)
Vol 31, No 34 (2024)
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview
Khator R., Biharee A., Bhatia N., Kulkarni S., Singh Y., Karthikeyan C., Jain A., Thareja S.
PDF
(Eng)
Vol 31, No 29 (2024)
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment
Ma C., Cui S., Xu R.
PDF
(Eng)
Vol 31, No 16 (2024)
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis
Saha A., Pushpa , Moitra S., Basak D., Brahma S., Mondal D., Molla S., Samadder A., Nandi S.
PDF
(Eng)
Vol 31, No 8 (2024)
Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases
Chen Y., Li X.
PDF
(Eng)
Vol 31, No 33 (2024)
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021
Duncan C., Gunosewoyo H., Mocerino M., Payne A.
PDF
(Eng)
Vol 31, No 27 (2024)
Small Molecule Inhibitors against the Bacterial Pathogen Brucella
Wu Y., Guo Y., Ma Y., Yu H., Wang Z.
PDF
(Eng)
Vol 31, No 8 (2024)
A Review on Shikonin and its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases
Olatunde O., Yong J., Lu C., Ming Y.
PDF
(Eng)
Vol 31, No 32 (2024)
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy
Vijayan Y., Sandhu J., Harikumar K.
PDF
(Eng)
Vol 31, No 27 (2024)
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review
Cabeza M.
PDF
(Eng)
Vol 31, No 12 (2024)
The Structure-property Relationships of Clinically Approved Protease Inhibitors
Choi K.
PDF
(Eng)
Vol 31, No 7 (2024)
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases
Pi Z., Qiu X., Liu J., Shi Y., Zeng Z., Xiao R.
PDF
(Eng)
Vol 31, No 30 (2024)
Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer
Wang X., Jing H.
PDF
(Eng)
Vol 31, No 24 (2024)
Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors
Olgen S., Kaleli S., Karaca B., Demirel U., Bristow H.
PDF
(Eng)
1 - 30 of 30 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"